<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><description>姓药的来说药，带你进入最深层次的医药领域，把握医药动态，了解最新前沿！</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 23 Apr 2021 21:29:06 +0800</pubDate><image><url>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</url><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>自免明星靶点IL-17：从发现到靶向治疗</title><link>https://mp.weixin.qq.com/s/9l8o7MerYRyj_X5hXgk7XQ</link><description></description><content:encoded><![CDATA[自免明星靶点IL-17：从发现到靶向治疗]]></content:encoded><pubDate>Fri, 23 Apr 2021 19:47:59 +0800</pubDate></item><item><title>博际生物喊你入职啦！！！优质岗位等你来挑</title><link>https://mp.weixin.qq.com/s/uW8crplPtDvZdMhc7HpkAg</link><description></description><content:encoded><![CDATA[博际生物喊你入职啦！！！优质岗位等你来挑]]></content:encoded><pubDate>Fri, 23 Apr 2021 19:47:59 +0800</pubDate></item><item><title>肿瘤免疫治疗靶点及相关小分子抑制剂/激动剂</title><link>https://mp.weixin.qq.com/s/H4l7p-Aoxnz8hvmK9uyk8Q</link><description></description><content:encoded><![CDATA[肿瘤免疫治疗靶点及相关小分子抑制剂/激动剂]]></content:encoded><pubDate>Thu, 22 Apr 2021 19:53:45 +0800</pubDate></item><item><title>10-100万年薪，诚聘AI算法、肿瘤免疫、抗体药物科学家</title><link>https://mp.weixin.qq.com/s/MlPMNvEEjyhXubZ3WtlReA</link><description></description><content:encoded><![CDATA[10-100万年薪，诚聘AI算法、肿瘤免疫、抗体药物科学家]]></content:encoded><pubDate>Thu, 22 Apr 2021 19:53:45 +0800</pubDate></item><item><title>中美药品专利链接制度比较（附政策法规数据库）</title><link>https://mp.weixin.qq.com/s/6cIvjI52XTJ54qoTvtgixQ</link><description></description><content:encoded><![CDATA[中美药品专利链接制度比较（附政策法规数据库）]]></content:encoded><pubDate>Wed, 21 Apr 2021 19:47:59 +0800</pubDate></item><item><title>全球ADC药物研发概况</title><link>https://mp.weixin.qq.com/s/mCPJaquJ9xQPKPGnG4G6CA</link><description></description><content:encoded><![CDATA[全球ADC药物研发概况]]></content:encoded><pubDate>Tue, 20 Apr 2021 19:44:20 +0800</pubDate></item><item><title>PD-1/PD-L1相关药物发明的专利保护</title><link>https://mp.weixin.qq.com/s/3j8gp83E4sgAdhx4pxStdw</link><description></description><content:encoded><![CDATA[PD-1/PD-L1相关药物发明的专利保护]]></content:encoded><pubDate>Mon, 19 Apr 2021 06:12:17 +0800</pubDate></item><item><title>Nature科普视频| 一款新型疫苗是如何诞生的</title><link>https://mp.weixin.qq.com/s/8dtkNTepl5Kw5IzOzLBbmw</link><description></description><content:encoded><![CDATA[Nature科普视频| 一款新型疫苗是如何诞生的]]></content:encoded><pubDate>Sun, 18 Apr 2021 06:28:51 +0800</pubDate></item><item><title>FDA撤销了单克隆抗体Bamlanivimab的紧急使用授权</title><link>https://mp.weixin.qq.com/s/c2bVAEaYGl8NRjSvxxag3A</link><description></description><content:encoded><![CDATA[FDA撤销了单克隆抗体Bamlanivimab的紧急使用授权]]></content:encoded><pubDate>Sat, 17 Apr 2021 09:43:12 +0800</pubDate></item><item><title>抗SARS-CoV-2中和抗体的临床进展</title><link>https://mp.weixin.qq.com/s/mZJ-o2FhjWDrx-FjZLbw-A</link><description></description><content:encoded><![CDATA[抗SARS-CoV-2中和抗体的临床进展]]></content:encoded><pubDate>Sat, 17 Apr 2021 09:43:12 +0800</pubDate></item><item><title>创新蓝海，百药争鸣｜BiG七周年半壁江山阵容揭秘</title><link>https://mp.weixin.qq.com/s/v0QOhOv8PFfA2tT5AuG3Ag</link><description></description><content:encoded><![CDATA[创新蓝海，百药争鸣｜BiG七周年半壁江山阵容揭秘]]></content:encoded><pubDate>Sat, 17 Apr 2021 09:43:12 +0800</pubDate></item><item><title>双特异性抗体：on-target off-tumor毒性及克服策略</title><link>https://mp.weixin.qq.com/s/34IIx64TuHCwMOuLTvlDFg</link><description></description><content:encoded><![CDATA[双特异性抗体：on-target off-tumor毒性及克服策略]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:28:33 +0800</pubDate></item><item><title>共创未来，博际生物招贤纳士</title><link>https://mp.weixin.qq.com/s/5-Sqh5OR_WGdt1ZyWnuqKQ</link><description></description><content:encoded><![CDATA[共创未来，博际生物招贤纳士]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:28:33 +0800</pubDate></item><item><title>2021 AACR年会｜安德森癌症中心发现“癌症之王&#34;新靶标</title><link>https://mp.weixin.qq.com/s/2tV8tpxcL2wrJ4i58oNlFg</link><description></description><content:encoded><![CDATA[2021 AACR年会｜安德森癌症中心发现“癌症之王"新靶标]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:51:36 +0800</pubDate></item><item><title>2021 AACR年会｜蓝鸟报告溶瘤病毒打破实体肿瘤微环境，增强CAR-T细胞疗法疗效</title><link>https://mp.weixin.qq.com/s/2N7GpXNCjdYZHaKJt_hMfw</link><description></description><content:encoded><![CDATA[2021 AACR年会｜蓝鸟报告溶瘤病毒打破实体肿瘤微环境，增强CAR-T细胞疗法疗效]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:51:36 +0800</pubDate></item><item><title>抗体前沿碰撞RNA疗法｜BiG春季聚会*苏州站</title><link>https://mp.weixin.qq.com/s/GXnl-tzVkdVtbvEAJdsOlQ</link><description></description><content:encoded><![CDATA[抗体前沿碰撞RNA疗法｜BiG春季聚会*苏州站]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:51:36 +0800</pubDate></item><item><title>限时免费| 20余位专家共同打造顶尖生物药工艺线上系列培训</title><link>https://mp.weixin.qq.com/s/zE6a6IZ0cQ9wQDlwrhQGRg</link><description></description><content:encoded><![CDATA[限时免费| 20余位专家共同打造顶尖生物药工艺线上系列培训]]></content:encoded><pubDate>Thu, 15 Apr 2021 19:51:36 +0800</pubDate></item><item><title>罗氏新型Prot-2+1 TCB抗体</title><link>https://mp.weixin.qq.com/s/zR18XGHNf8ae_VfnR689aQ</link><description></description><content:encoded><![CDATA[罗氏新型Prot-2+1 TCB抗体]]></content:encoded><pubDate>Wed, 14 Apr 2021 20:37:45 +0800</pubDate></item><item><title>恐怖！怪异的蝴蝶、畸形的蚜虫... 福岛核事故引发的生物变异还在继续！</title><link>https://mp.weixin.qq.com/s/nc2jGIRnJ-TWvgxhHKZXJQ</link><description></description><content:encoded><![CDATA[恐怖！怪异的蝴蝶、畸形的蚜虫... 福岛核事故引发的生物变异还在继续！]]></content:encoded><pubDate>Wed, 14 Apr 2021 20:37:45 +0800</pubDate></item></channel></rss>